• 33656 Citations
  • 92 Scopus h-Index
1976 …2020
If you made any changes in Pure, your changes will be visible here soon.

Projects 1985 2020

Active
Death Domain Receptors
Ligands
Apoptosis
Cell Death
Immunotherapy
Ovarian Neoplasms
Mutation
Down-Regulation
Double-Stranded DNA Breaks
Neoplasms

Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer

Kaufmann, S. H., Cliby, W. A., Bible, K. C., Goode, E. L., Galanis, E., Knutson, K. L., Hartmann, L. C., Oberg, A. L., Couch, F. J., Fields, A. P., Haluska, P. R. J., Long, H., Bell, D., Keeney, G., Lengyel, E., Keeney, G., Shridhar, V., Cliby, W. A., Goode, E. L., Peng, K., Hartmann, L. C. & Lingle, W. L.

National Institutes of Health

10/1/088/31/20

Project: Research project

Ovarian Neoplasms
alvocidib
Registries
Research
Translational Medical Research
Finished
Mitochondrial Membranes
bcl-2 Homologous Antagonist-Killer Protein
Noxae
Pharmaceutical Preparations
Proteins

Medical Scientist Training Program at Mayo Clinic

Isaya, G., Rodriguez, M., Rodriguez, M., Lee, K. H. & Kaufmann, S. H.

National Institutes of Health

7/1/036/30/18

Project: Research project

training program
Students
student
Medical Schools
physician

Lymphoma Specialized Program of Research Excellence

Macon, W. R., Dogan, A. M., Ansell, S. M., Gupta, M. D., Witzig, T. E., Cerhan, J. R., Habermann, T. M., Ratliff, T. L., Link, B. K., Ratliff, T. L., Juweid, M., Ballas, Z., Link, B. K., Ratliff, T., Geyer, S. M., Weiner, G., Lentz, S., Hohl, R., Smith, B. J., Kaufmann, S. H., Feldman, A. L. & Witzig, T. E.

National Institutes of Health

9/11/026/30/17

Project: Research project

Lymphoma
Non-Hodgkin's Lymphoma
Molecular Epidemiology
B-Lymphocytes
B-Cell Lymphoma
NSC 680410
Tyrphostins
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia
Phosphotransferases
Drug Therapy
DNA Repair
Antineoplastic Agents
Neoplasms
Cytotoxins
Topoisomerase I Inhibitors
irinotecan
Type I DNA Topoisomerase
Leukemia
Poisons
Multiple Drug Resistance
NAD
Topotecan
Type I DNA Topoisomerase
Lung Neoplasms
Peptide Hydrolases
Apoptosis
Drug Therapy
Death Domain Receptors
Aspartic Acid
Type II DNA Topoisomerase
Poisons
Etoposide
DNA Adducts
DNA Damage
Type II DNA Topoisomerase
Drug Resistance
Acute Myeloid Leukemia
Leukemia
Amsacrine